Mikkel Viltoft
Directeur Général chez Novozymes Biopharma DK A/S
Profil
Mikkel Viltoft is currently the Chief Executive Officer at Novozymes Biopharma DK A.
He is also the Chairman at Novozymes BioloAg.
A, Novozymes Bioindustrial China A, and the Director at Novozymes South Asia Pvt Ltd.
Additionally, he serves as the Co-Managing Director at Novozymes Deutschland GmbH.
Previously, he held positions as the Chairman at Novozymes France SAS and the General Counsel at Novozymes A.
Postes actifs de Mikkel Viltoft
| Sociétés | Poste | Début |
|---|---|---|
Novozymes South Asia Pvt Ltd.
 Novozymes South Asia Pvt Ltd. Pharmaceuticals: OtherHealth Technology Novozymes South Asia Pvt Ltd. develops and produces enzyme products. The company was founded in 1983 and is headquartered in Bangalore, India. | Directeur/Membre du Conseil | - |
Novozymes Bioindustrial China A/S
 Novozymes Bioindustrial China A/S BiotechnologyHealth Technology Novozymes Bioindustrial China A/S invests in research and development as well as production of biotechnological products and processes. The company was founded on January 1, 1999 and is headquartered in Bagsvaerd, Denmark. | Président | 21/05/2010 |
Novozymes Biopharma DK A/S
 Novozymes Biopharma DK A/S Pharmaceuticals: MajorHealth Technology Novozymes Biopharma DK A/S engages in the wholesale of pharmaceuticals and medical article. The firm operates and invests in research, development, production, and trade in biological solutions, including pharmaceuticals, and biotechnology products and processes.The company was founded on May 29, 2006 and is headquartered in Bagsvaerd, Denmark. | Directeur Général | - |
Novozymes BioloAg A/S
 Novozymes BioloAg A/S BiotechnologyHealth Technology Novozymes BioloAg A/S provides research and development for biotechnology products and processes. It participates in The BioAg Alliance to commercialize BioAg assets and competencies within microbial research, development, and production. The company was founded on October 22, 2007 and is headquartered in Bagsvaerd, Denmark. | Président | 21/05/2010 |
Novozymes Deutschland GmbH
 Novozymes Deutschland GmbH BiotechnologyHealth Technology Part of Novonesis A/S, Novozymes Deutschland GmbH is a German company that develops bacterial and virus vaccines, toxoids, and analogous products. The company is based in Bad Kreuznach, Germany. The CEOs are Mikkel Viltoft and Randi Camilla Kinch Jensen. The company was founded in 2003. | Directeur Général | - |
Anciens postes connus de Mikkel Viltoft
| Sociétés | Poste | Fin |
|---|---|---|
Novozymes France SAS
 Novozymes France SAS BiotechnologyHealth Technology Novozymes France SAS develops and manufactures biopharmaceutical products. The company was founded on October 8, 1976 and is headquartered in Le Pecq, France. | Président | - |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Conseiller Juridique Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
Novozymes South Asia Pvt Ltd.
Novozymes South Asia Pvt Ltd. Pharmaceuticals: OtherHealth Technology Novozymes South Asia Pvt Ltd. develops and produces enzyme products. The company was founded in 1983 and is headquartered in Bangalore, India. | Health Technology |
Novozymes BioloAg A/S
Novozymes BioloAg A/S BiotechnologyHealth Technology Novozymes BioloAg A/S provides research and development for biotechnology products and processes. It participates in The BioAg Alliance to commercialize BioAg assets and competencies within microbial research, development, and production. The company was founded on October 22, 2007 and is headquartered in Bagsvaerd, Denmark. | Health Technology |
Novozymes France SAS
Novozymes France SAS BiotechnologyHealth Technology Novozymes France SAS develops and manufactures biopharmaceutical products. The company was founded on October 8, 1976 and is headquartered in Le Pecq, France. | Health Technology |
Novozymes Biopharma DK A/S
Novozymes Biopharma DK A/S Pharmaceuticals: MajorHealth Technology Novozymes Biopharma DK A/S engages in the wholesale of pharmaceuticals and medical article. The firm operates and invests in research, development, production, and trade in biological solutions, including pharmaceuticals, and biotechnology products and processes.The company was founded on May 29, 2006 and is headquartered in Bagsvaerd, Denmark. | Health Technology |
Novozymes Bioindustrial China A/S
Novozymes Bioindustrial China A/S BiotechnologyHealth Technology Novozymes Bioindustrial China A/S invests in research and development as well as production of biotechnological products and processes. The company was founded on January 1, 1999 and is headquartered in Bagsvaerd, Denmark. | Health Technology |
Novozymes Deutschland GmbH
Novozymes Deutschland GmbH BiotechnologyHealth Technology Part of Novonesis A/S, Novozymes Deutschland GmbH is a German company that develops bacterial and virus vaccines, toxoids, and analogous products. The company is based in Bad Kreuznach, Germany. The CEOs are Mikkel Viltoft and Randi Camilla Kinch Jensen. The company was founded in 2003. | Health Technology |
